Variant report

Variant	nsv491979
Chromosome Location	chr9:207437-416351
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2346)
CpG islands
(count:489)
Chromatin interactive
region (count:153)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2346 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
2	ARID3A	chr9:336046-336405	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
4	ARID3A	chr9:272758-273406	K562	blood:	n/a	chr9:273064-273079
5	ARID3A	chr9:215966-216247	K562	blood:	n/a	n/a
6	ARID3A	chr9:214214-215154	K562	blood:	n/a	n/a
7	ARID3A	chr9:371491-371553	K562	blood:	n/a	n/a
8	ARID3A	chr9:210220-210873	K562	blood:	n/a	n/a
9	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
10	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
11	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
12	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
13	ARID3A	chr9:272095-272522	K562	blood:	n/a	n/a
14	ATF1	chr9:272150-272512	K562	blood:	n/a	n/a
15	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
16	ATF1	chr9:272781-273161	K562	blood:	n/a	n/a
17	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
18	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
19	ATF1	chr9:312958-313372	K562	blood:	n/a	n/a
20	ATF1	chr9:211078-211816	K562	blood:	n/a	n/a
21	ATF2	chr9:272650-273286	GM12878	blood:	n/a	n/a
22	ATF2	chr9:297286-297859	GM12878	blood:	n/a	n/a
23	ATF2	chr9:272677-273240	GM12878	blood:	n/a	n/a
24	ATF3	chr9:326568-327022	H1-hESC	embryonic stem cell:	n/a	n/a
25	ATF3	chr9:210212-210461	K562	blood:	n/a	n/a
26	ATF3	chr9:272081-272576	K562	blood:	n/a	n/a
27	BACH1	chr9:214677-214706	H1-hESC	embryonic stem cell:	n/a	n/a
28	BACH1	chr9:207498-207603	K562	blood:	n/a	n/a
29	BACH1	chr9:214910-215270	H1-hESC	embryonic stem cell:	n/a	n/a
30	BATF	chr9:297420-297885	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
31	BATF	chr9:297422-297902	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
32	BATF	chr9:278668-278987	GM12878	blood:	n/a	n/a
33	BCL11A	chr9:331212-331567	H1-hESC	embryonic stem cell:	n/a	n/a
34	BCLAF1	chr9:307023-307293	GM12878	blood:	n/a	n/a
35	BCLAF1	chr9:297419-297950	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
36	BCLAF1	chr9:214465-215559	GM12878	blood:	n/a	n/a
37	BCLAF1	chr9:272677-273191	GM12878	blood:	n/a	chr9:272862-272871
38	BCLAF1	chr9:297343-297922	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
39	BCLAF1	chr9:272658-273387	GM12878	blood:	n/a	chr9:272862-272871
40	BHLHE40	chr9:214106-214306	K562	blood:	n/a	n/a
41	BHLHE40	chr9:270725-270976	GM12878	blood:	n/a	n/a
42	BHLHE40	chr9:214650-215428	K562	blood:	n/a	n/a
43	BHLHE40	chr9:297517-297717	K562	blood:	n/a	n/a
44	BHLHE40	chr9:259627-260475	K562	blood:	n/a	n/a
45	BHLHE40	chr9:209140-209345	K562	blood:	n/a	n/a
46	BHLHE40	chr9:218973-219054	K562	blood:	n/a	n/a
47	BHLHE40	chr9:272179-272510	K562	blood:	n/a	n/a
48	BHLHE40	chr9:214569-215152	GM12878	blood:	n/a	n/a
49	BHLHE40	chr9:214709-215301	HepG2	liver:	n/a	n/a
50	BHLHE40	chr9:211108-211404	K562	blood:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:214612-214662	CMK	blood:	n/a
2	chr9:214612-214662	CMK	blood:	n/a
3	chr9:214268-214318	NT2-D1	testis:	n/a
4	chr9:215368-215418	T-47D	breast:	n/a
5	chr9:214612-214662	HPAEpiC	pulmonary alveolar:	n/a
6	chr9:211689-211739	SAEC	small airway:	n/a
7	chr9:213650-213700	GM12878	blood:	n/a
8	chr9:214612-214662	A549	lung:	n/a
9	chr9:213650-213700	CMK	blood:	n/a
10	chr9:214690-214740	PrEC	prostate:	n/a
11	chr9:214612-214662	GM12891	blood:	n/a
12	chr9:214612-214662	GM19239	blood:	n/a
13	chr9:215368-215418	AG09309	skin:	n/a
14	chr9:214612-214662	AG04449	skin:	fetal
15	chr9:214268-214318	AG04450	lung:	fetal
16	chr9:214690-214740	A549	lung:	n/a
17	chr9:214690-214740	ProgFib	skin:	n/a
18	chr9:215561-215611	MCF-7	breast:	n/a
19	chr9:214690-214740	NB4	blood:	n/a
20	chr9:215368-215418	Hela-S3	cervix:	n/a
21	chr9:215561-215611	U87	brain:	n/a
22	chr9:211689-211739	H1-hESC	embryonic stem cell:	embryo
23	chr9:273072-273122	NHBE	bronchial:	n/a
24	chr9:214268-214318	Hela-S3	cervix:	n/a
25	chr9:211689-211739	U87	brain:	n/a
26	chr9:211689-211739	HRPEpiC	eye:	n/a
27	chr9:215368-215418	SKMC	muscle:	n/a
28	chr9:214612-214662	AG09309	skin:	n/a
29	chr9:211689-211739	AG09319	gingival:	n/a
30	chr9:211689-211739	HAEpiC	amniotic membrane:	n/a
31	chr9:273072-273122	Jurkat	blood:	n/a
32	chr9:215561-215611	SK-N-SH_RA	brain:	n/a
33	chr9:215368-215418	GM06990	blood:	n/a
34	chr9:214690-214740	AG10803	skin:	n/a
35	chr9:215368-215418	NB4	blood:	n/a
36	chr9:214612-214662	HCPEpiC	choroid plexus:	n/a
37	chr9:214268-214318	AG09309	skin:	n/a
38	chr9:215561-215611	NHBE	bronchial:	n/a
39	chr9:215368-215418	PANC-1	pancreas:	n/a
40	chr9:213650-213700	SK-N-SH	brain:	n/a
41	chr9:215368-215418	RPTEC	kidney:	n/a
42	chr9:273072-273122	K562	blood:	n/a
43	chr9:211689-211739	GM12892	blood:	n/a
44	chr9:215561-215611	IMR90	lung:	fetal
45	chr9:214612-214662	SK-N-SH_RA	brain:	n/a
46	chr9:214612-214662	ProgFib	skin:	n/a
47	chr9:273072-273122	NB4	blood:	n/a
48	chr9:213650-213700	AG09309	skin:	n/a
49	chr9:214268-214318	SK-N-SH_RA	brain:	n/a
50	chr9:211689-211739	MCF-7	breast:	n/a

(count:153 , 50 per page) page: 1 2 3 4

No.	Distal block	Cell Line	Cell type
1	chr9:387700..389795-chr9:395557..397565,2	MCF-7	breast:
2	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
3	chr9:303334..306488-chr9:313112..315414,3	MCF-7	breast:
4	chr9:288330..291260-chr9:302503..304653,3	K562	blood:
5	chr9:285389..289218-chr9:290727..294143,4	K562	blood:
6	chr9:288365..290115-chr9:299185..301598,2	MCF-7	breast:
7	chr9:214778..216543-chr9:219574..221163,2	MCF-7	breast:
8	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
9	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
10	chr9:235818..237375-chr9:247234..248835,2	K562	blood:
11	chr9:219964..222537-chr9:271277..273964,2	K562	blood:
12	chr9:213587..215367-chr9:247326..250011,2	MCF-7	breast:
13	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
14	chr9:268983..271562-chr9:284279..286719,2	MCF-7	breast:
15	chr9:347437..348401-chr9:378296..379161,3	MCF-7	breast:
16	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
17	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
18	chr9:210056..211721-chr9:271493..274380,2	K562	blood:
19	chr9:213518..215162-chr9:305580..308186,2	K562	blood:
20	chr9:275975..278627-chr9:279451..282123,3	K562	blood:
21	chr9:316274..318543-chr9:331270..334145,2	MCF-7	breast:
22	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
23	chr9:387700..389795-chr9:395557..397565,2	MCF-7	breast:
24	chr9:286841..289218-chr9:291668..294143,2	K562	blood:
25	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
26	chr9:217275..219531-chr9:301975..303827,2	MCF-7	breast:
27	chr9:284961..287002-chr9:306876..309185,2	K562	blood:
28	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
29	chr9:258428..261727-chr9:265742..268870,3	K562	blood:
30	chr9:276287..280123-chr9:282139..284880,4	K562	blood:
31	chr9:277861..283096-chr9:291676..296273,5	K562	blood:
32	chr9:218197..221460-chr9:224650..228237,4	K562	blood:
33	chr9:244363..245872-chr9:248878..250809,2	K562	blood:
34	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
35	chr9:276314..278461-chr9:285139..287718,2	K562	blood:
36	chr9:347478..348338-chr9:806313..807172,2	MCF-7	breast:
37	chr9:396391..399763-chr9:403196..405645,3	K562	blood:
38	chr9:214285..216173-chr9:227690..229444,2	K562	blood:
39	chr9:318530..320927-chr9:322721..325349,2	K562	blood:
40	chr9:253544..257279-chr9:268731..273892,6	K562	blood:
41	chr9:207956..209819-chr9:211466..213662,2	MCF-7	breast:
42	chr9:347287..349476-chr9:362112..363970,2	MCF-7	breast:
43	chr9:268889..271022-chr9:277493..279614,2	K562	blood:
44	chr9:255761..258409-chr9:263285..266102,2	K562	blood:
45	chr9:385494..386481-chr9:546680..547596,3	MCF-7	breast:
46	chr9:244363..245872-chr9:248878..250809,2	K562	blood:
47	chr9:250806..252981-chr9:269858..272236,2	MCF-7	breast:
48	chr9:211790..213319-chr9:241598..244495,2	K562	blood:
49	chr9:326951..329483-chr9:330404..332162,2	K562	blood:
50	chr9:209849..211411-chr9:213516..215617,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf66-1	chr9:267966-268273	ENSG00000235880.1
2	lnc-C9orf66-1	chr9:272905-273002	ENSG00000235880.1

No data

Variant related genes	Relation type
DOCK8	TF binding region
ENSG00000235880	TF binding region
C9orf66	TF binding region
DOCK8	CpG island
ENSG00000235880	CpG island
C9orf66	CpG island
ENSG00000107099	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000101191	chromatin interactions
ENSG00000226403	chromatin interactions
ENSG00000227155	chromatin interactions
ENSG00000183784	chromatin interactions

Extended variants
information (count: 11646 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:11646 , 50 per page) page: 1 2 3 4 5 6 7 ... 233

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146757309	chr9:207449-207450	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs533567	chr9:207454-207455	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs373248145	chr9:207494-207495	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs543497437	chr9:207514-207515	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs565005883	chr9:207521-207522	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs532393090	chr9:207531-207532	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs201315246	chr9:207550-207551	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs139052320	chr9:207625-207626	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs116313693	chr9:207637-207638	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs531308192	chr9:207640-207641	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs529939656	chr9:207652-207653	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs143997654	chr9:207697-207698	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs567243742	chr9:207713-207714	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs569731664	chr9:207714-207715	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs370815638	chr9:207717-207718	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs537207448	chr9:207721-207722	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs558705813	chr9:207723-207724	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs570513843	chr9:207740-207741	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs530776	chr9:207755-207756	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs182834005	chr9:207776-207777	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs150950860	chr9:207788-207789	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs553034837	chr9:207808-207809	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs187382992	chr9:207845-207846	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs555177174	chr9:207882-207883	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs377447680	chr9:207894-207895	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs572817280	chr9:207896-207897	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs576246065	chr9:207905-207906	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs543583194	chr9:207919-207920	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs528912	chr9:207958-207959	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs532429310	chr9:208056-208057	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs541588645	chr9:208057-208058	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs367998005	chr9:208093-208094	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs558763203	chr9:208132-208133	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs541458283	chr9:208157-208158	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs559486851	chr9:208168-208169	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs111467385	chr9:208177-208178	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs10964297	chr9:208181-208182	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs150241723	chr9:208241-208242	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs548174576	chr9:208263-208264	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs569902927	chr9:208286-208287	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs73370574	chr9:208289-208290	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs552358179	chr9:208292-208293	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs190869469	chr9:208354-208355	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs534704680	chr9:208389-208390	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs183040851	chr9:208419-208420	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs187410442	chr9:208431-208432	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs145834118	chr9:208440-208441	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs76287109	chr9:208516-208517	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs576282800	chr9:208527-208528	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs644809	chr9:208549-208550	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:121)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Schizophrenia	20967226	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:2793 , 50 per page) page: 1 2 3 4 5 6 7 ... 56

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:206600-208800	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr9:207000-208400	Weak transcription	Monocytes-CD14+_RO01746	blood
3	chr9:207200-207800	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr9:207800-213600	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr9:208000-208800	Enhancers	K562	blood
6	chr9:208400-208600	Enhancers	Monocytes-CD14+_RO01746	blood
7	chr9:208600-209800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
8	chr9:208800-209800	Enhancers	Primary hematopoietic stem cells short term culture	blood
9	chr9:208800-209800	Flanking Active TSS	K562	blood
10	chr9:208800-213200	Enhancers	Primary neutrophils fromperipheralblood	blood
11	chr9:209200-209800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr9:209200-209800	Enhancers	Spleen	Spleen
13	chr9:209800-210400	Enhancers	Monocytes-CD14+_RO01746	blood
14	chr9:209800-211000	Weak transcription	Spleen	Spleen
15	chr9:209800-213400	Enhancers	K562	blood
16	chr9:209800-213600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
17	chr9:209800-214000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr9:210400-210600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
19	chr9:210600-211000	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr9:210600-211400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr9:210800-212600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr9:211000-211400	Enhancers	Pancreas	Pancrea
23	chr9:211000-211400	Enhancers	Spleen	Spleen
24	chr9:211000-214600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
25	chr9:211200-211400	Enhancers	Placenta	Placenta
26	chr9:211200-212200	Enhancers	Adipose Nuclei	Adipose
27	chr9:211400-211600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
28	chr9:211400-212000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr9:211400-212200	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr9:211400-213600	Weak transcription	Pancreas	Pancrea
31	chr9:211400-214000	Enhancers	Primary B cells from cord blood	blood
32	chr9:211400-214000	Weak transcription	Spleen	Spleen
33	chr9:211600-211800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
34	chr9:211800-212600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
35	chr9:212000-214400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr9:212200-214000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
37	chr9:212200-214000	Weak transcription	Adipose Nuclei	Adipose
38	chr9:212400-213000	Enhancers	Primary hematopoietic stem cells	blood
39	chr9:212600-212800	Bivalent/Poised TSS	Fetal Kidney	kidney
40	chr9:212600-212800	Enhancers	Skeletal Muscle Female	skeletal muscle
41	chr9:212600-213000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
42	chr9:212600-213600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr9:213000-214000	Weak transcription	Primary hematopoietic stem cells	blood
44	chr9:213000-215200	Active TSS	Brain Substantia Nigra	brain
45	chr9:213200-213400	Bivalent/Poised TSS	Fetal Kidney	kidney
46	chr9:213200-214400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
47	chr9:213400-213800	Flanking Active TSS	K562	blood
48	chr9:213400-214600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr9:213600-214000	Enhancers	Primary B cells from peripheral blood	blood
50	chr9:213600-214000	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links